As of 2025-11-22, the Relative Valuation of Exact Sciences Corp (EXAS) is (100.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 100.90 USD, the upside of Exact Sciences Corp based on Relative Valuation is -199.7%.
The range of the Relative Valuation is (91.51) - (102.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 22.8x | 20.2x |
| Forward P/E multiples | 15.4x - 19.8x | 18.4x |
| Fair Price | (91.51) - (102.97) | (100.58) |
| Upside | -190.7% - -202.1% | -199.7% |
| Date | P/E |
| 2025-11-21 | -19.36 |
| 2025-11-20 | -19.32 |
| 2025-11-19 | -16.54 |
| 2025-11-18 | -13.37 |
| 2025-11-17 | -12.89 |
| 2025-11-14 | -12.86 |
| 2025-11-13 | -13.00 |
| 2025-11-12 | -13.12 |
| 2025-11-11 | -12.95 |
| 2025-11-10 | -12.78 |
| 2025-11-07 | -12.70 |
| 2025-11-06 | -12.90 |
| 2025-11-05 | -13.36 |
| 2025-11-04 | -13.35 |
| 2025-11-03 | -12.85 |
| 2025-10-31 | -12.41 |
| 2025-10-30 | -12.13 |
| 2025-10-29 | -12.04 |
| 2025-10-28 | -12.15 |
| 2025-10-27 | -12.19 |
| 2025-10-24 | -12.40 |
| 2025-10-23 | -12.44 |
| 2025-10-22 | -12.07 |
| 2025-10-21 | -12.17 |
| 2025-10-20 | -12.04 |
| 2025-10-17 | -11.75 |
| 2025-10-16 | -11.76 |
| 2025-10-15 | -11.63 |
| 2025-10-14 | -11.62 |
| 2025-10-13 | -11.39 |
| 2025-10-10 | -11.20 |
| 2025-10-09 | -11.41 |
| 2025-10-08 | -11.38 |
| 2025-10-07 | -11.08 |
| 2025-10-06 | -11.06 |
| 2025-10-03 | -10.88 |
| 2025-10-02 | -10.78 |
| 2025-10-01 | -10.83 |
| 2025-09-30 | -10.50 |
| 2025-09-29 | -10.24 |
| 2025-09-26 | -10.28 |
| 2025-09-25 | -10.30 |
| 2025-09-24 | -10.19 |
| 2025-09-23 | -10.06 |
| 2025-09-22 | -10.28 |
| 2025-09-19 | -10.23 |
| 2025-09-18 | -10.28 |
| 2025-09-17 | -10.05 |
| 2025-09-16 | -10.16 |
| 2025-09-15 | -10.25 |